Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Innoviz Technologies (INVZ) PT Lowered to $3 at Cantor Fitzgerald
-
Cantor Fitzgerald Upgrades EVgo, Inc. (EVGO) to Overweight
-
Cantor Fitzgerald Starts Perspective Therapeutics Inc (CATX) at Overweight
-
GP-Act III Acquisition Corp. Announces the Pricing of $250 Million Initial Public Offering
-
Orchid Island Capital Announces May 2024 Monthly Dividend and April 30, 2024 RMBS Portfolio Characteristics
-
Shoals Technologies Group (SHLS) PT Lowered to $14 at Cantor Fitzgerald
-
Rivian Automotive Inc (RIVN) PT Lowered to $15 at Cantor Fitzgerald
-
Cantor Fitzgerald Reiterates Overweight Rating on Datadog (DDOG)
-
Rubicon Technologies (RBT) Sells Fleet Technology Business Unit, Issues Preferred Equity
-
Rubicon Announces Sale of Fleet Technology Business Unit and Issuance of Preferred Equity
-
Capital Square Hires Industry Veteran John Dunn as Senior Regional Vice President, South Central Territory
-
Form 8-K Cantor Fitzgerald Income For: May 06
-
Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebant
-
ADC Therapeutics SA (ADCT) Prices $105M Share and Warrant Offering at $4.9/sh
-
ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants
-
Form 424B3 CANTOR FITZGERALD INFRAS
-
CIGNA (CI) PT Raised to $400 at Cantor Fitzgerald
-
Cerus (CERS) PT Raised to $4 at Cantor Fitzgerald
-
Sprout Social Inc. (SPT) PT Lowered to $46 at Cantor Fitzgerald
-
Cloudflare Inc. (NET) PT Lowered to $80 at Cantor Fitzgerald
-
Fortinet (FTNT) PT Lowered to $55 at Cantor Fitzgerald
-
Soleno Therapeutics (SLNO) Announces Pricing of $138 Mln Public Offering Of Common Stock
-
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock
-
Cantor is bullish on FSD, starts Tesla (TSLA) stock at buy
-
Cantor Fitzgerald Starts Tesla (TSLA) at Overweight, 'good entry-point for investors'
-
AMD (AMD) PT Lowered to $170 at Cantor Fitzgerald
-
Form EFFECT CANTOR FITZGERALD INFRAS
-
TriSalus Life Sciences (TLSI) Secures $50M Debt Financing with OrbiMed
-
TriSalus Life Sciences Secures up to $50 million of Debt Financing with OrbiMed to Support TriNavĀ® Infusion System Growth Initiatives
-
Form 13F-HR CANTOR FITZGERALD INVEST For: Mar 31
-
Eli Lilly (LLY) PT Raised to $885 at Cantor Fitzgerald
-
Coursera Inc (COUR) PT Lowered to $21 at Cantor Fitzgerald
-
Form 40-17G CANTOR FITZGERALD INFRAS
-
Form 486APOS CANTOR FITZGERALD INFRAS
-
Orchid Island Capital Announces First Quarter 2024 Results
-
Humana (HUM) PT Lowered to $360 at Cantor Fitzgerald
-
Cantor Fitzgerald Starts Materialise NV (MTLS) at Overweight, 'Well-Positioned to meet rising software demand'
-
TSX Venture Exchange Stock Maintenance Bulletins
-
Cantor Fitzgerald Starts Incyte (INCY) at Neutral, 'JAK-ing Up Its Pipeline In Advance of a Major Patent Cliff'
-
Form 424B3 Cantor Fitzgerald Income
-
Rio2 Closes C$23M Offering
-
FRONT ROW HUNTSVILLE ENTERS NEXT PHASE WITH GROUNDBREAKING CEREMONY
-
Eli Lilly (LLY) sleep apnea study data seen as a win, stock gains
-
Kroll Appoints Karen Laureano-Rikardsen as Chief Marketing and Communications Officer
-
Marinus Pharmaceuticals (MRNS) PT Lowered to $13 at Cantor Fitzgerald
-
Cantor Fitzgerald Starts Klaviyo Inc (KVYO) at Overweight
-
Fannie Mae Prices $628 Million Connecticut Avenue Securities (CAS) REMIC Deal
-
Cantor Fitzgerald Upgrades SoundHound AI Inc. (SOUN) to Neutral
-
Orchid Island Capital (ORC) Announces Estimated First Quarter 2024 Results, April 2024 Monthly Dividend and March 31, 2024 RMBS Portfolio Characteristics
-
Orchid Island Capital Announces Estimated First Quarter 2024 Results, April 2024 Monthly Dividend and March 31, 2024 RMBS Portfolio Characteristics

